Results 201 to 210 of about 2,467,830 (354)

C-H bond activation catalyzed by Ruthenium nanoparticles

, 2017
Long‐Hui Gao
openalex   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Iron tris-mesityl: a homoleptic iron(ii) ferrate species for directed C-H activation. [PDF]

Chem Sci
Radović A, Healy MC, Datta A, Das D, Cai L, Diaz S, Gogoi AR, Wolford NJ, Carpenter SH, Brenessel WW, McCamant D, Gutierrez O, Neidig ML.   +12 more
europepmc   +1 more source

Nickel-catalysed enantioselective alkene dicarbofunctionalization enabled by photochemical aliphatic C–H bond activation [PDF]

Xia Hu, Iván Cheng‐Sánchez, Wangqing Kong, Gary A. Molander, Cristina Nevado   +4 more
openalex   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Synthesis of Heteroannulated Indolopyrazines through Domino N–H Palladium-Catalyzed/Metal-Free Oxidative C–H Bond Activation

ACS Omega, 2020
Yuriy A. Kvashnin, Egor V. Verbitskiy, Ekaterina F. Zhilina, Gennady L. Rusinov, Oleg N. Chupakhin, Valery N. Charushin   +5 more
doaj   +1 more source

Correction: Iron tris-mesityl: a homoleptic iron(ii) ferrate species for directed C-H activation. [PDF]

Chem Sci
Radović A, Healy MC, Datta A, Das D, Cai L, Diaz S, Gogoi AR, Wolford NJ, Carpenter SH, Brenessel WW, McCamant D, Gutierrez O, Neidig ML.   +12 more
europepmc   +1 more source

Complexes of non-noble metals of iron and nickel bearing redox non-innocent ligands and their catalytic applications : from C-H activation to cross-coupling reactions

, 2014
Elise Salanouve
openalex   +1 more source

Palladium(II)-Catalyzed Tandem Oxidative Acetoxylation/ortho C–H Activation/Carbocyclization of Arylallenes

, 2015
Javier Mazuela, Debasis Banerjee, Jan‐E. Bäckvall   +2 more
openalex   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source